by jlohrconsulting | Oct 31, 2025 | Uncategorized
Eur J Psychotraumatol. 2025 Dec;16(1):2572850. doi: 10.1080/20008066.2025.2572850. Epub 2025 Oct 31. ABSTRACT Background: Most adults have experienced at least one Potentially Traumatic Event (PTE) in their life. Yet, many individuals who develop adverse outcomes such...
by jlohrconsulting | Oct 31, 2025 | Uncategorized
Psychooncology. 2025 Nov;34(11):e70313. doi: 10.1002/pon.70313. ABSTRACT BACKGROUND: The Cancer Behavior Inventory Brief Form (CBI-B) allows assessing self-efficacy for coping with cancer as a personal resource of patients facing a diagnosis of cancer and its...
by jlohrconsulting | Oct 31, 2025 | Uncategorized
Cardiol J. 2025 Oct 31. doi: 10.5603/cj.103954. Online ahead of print. ABSTRACT BACKGROUND: Heart failure (HF) is a leading cause of hospitalization and mortality, regardless of left ventricular ejection fraction (LVEF). The prevalence of HF with preserved and mildly...
by jlohrconsulting | Oct 31, 2025 | Uncategorized
Br J Community Nurs. 2025 Nov 2;30(11):514-519. doi: 10.12968/bjcn.2025.0055. ABSTRACT Frailty is a multidimensional syndrome commonly associated with older age and characterised by reduced physical, mental and social reserve. Prevalence rates for frailty in older...
by jlohrconsulting | Oct 31, 2025 | Uncategorized
J Manag Care Spec Pharm. 2025 Nov;31(11):1203-1206. doi: 10.18553/jmcp.2025.31.11.1203. NO ABSTRACT PMID:41171071 | DOI:10.18553/jmcp.2025.31.11.1203
by jlohrconsulting | Oct 31, 2025 | Uncategorized
Hum Brain Mapp. 2025 Nov;46(16):e70383. doi: 10.1002/hbm.70383. ABSTRACT Major depressive disorder (MDD) exhibits substantial neurobiological heterogeneity that complicates treatment selection and mechanistic understanding. While conventional group-level analyses...
Recent Comments